GL1X · GenesisL1 explorer

MolNFT v1 · #125668 · protein

AlphaFold monomer V2.0 prediction for fanconi anemia group D2 protein (Q9BXW9)

Q9BXW9: “AlphaFold monomer V2.0 prediction for fanconi anemia group D2 protein (Q9BXW9)”. MolNFT v1 #125668 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

Accession
Q9BXW9
Type
protein
Length
1,451 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xBF0D2e107Ce1EcD2C4369B042274201DB719AaAF
UniProt
Q9BXW9

Structure

1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein1451—Q9BXW9

Compared structures

  • 6VAA · Structure of the fanconi anemia id complex bound to icl DNA · an experimental structure of the same protein · chain A against B, TM-score 0.69
  • 6VAD · Fanconi anemia id complex · an experimental structure of the same protein · chain A against B, TM-score 0.68
  • 7KZR · Structure of the human Fanconi Anaemia Core-UBE2T-ID complex · an experimental structure of the same protein · chain A against V, TM-score 0.67
  • 7KZT · Structure of the human fanconi anaemia Core-UBE2T-ID-DNA complex in intermediate state · an experimental structure of the same protein · chain A against V, TM-score 0.64
  • 6VAE · Mono-ubiquitinated fanconi anemia id complex bound to icl DNA · an experimental structure of the same protein · chain A against B, TM-score 0.62
  • 6VAF · Structure of mono-ubiquitinated FANCD2 bound to non-ubiquitinated FANCI and to DNA · an experimental structure of the same protein · chain A against B, TM-score 0.62
  • 6VAF · Structure of mono-ubiquitinated FANCD2 bound to non-ubiquitinated fanci and to DNA · an experimental structure of the same protein · chain A against B, TM-score 0.62
  • 7AY1 · Cryo-EM structure of USP1-UAF1 bound to mono-ubiquitinated FANCD2, and fanci · an experimental structure of the same protein · chain A against B, TM-score 0.60

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.